WebParis (France), September 18th, 2024 - Horama (www.horama.fr), a French biotech company based in Paris and Nantes, which specialises in gene therapy for the treatment … Web18 sep. 2024 · Paris (France), September 18th, 2024 - Horama (www.horama.fr), a French biotech company based in Paris and Nantes, which specialises in gene therapy for the treatment of rare genetic diseases in ...
Horama Raises €19 Million in a Series B Financing Round
WebJan 2007 - Jun 20136 years 6 months. Paris, France. Alfact Innovation is a privately owned biotech company dedicated to the development of biopharmaceuticals for the treatment … Web[PRESSE] "French Biotech Raises €19M for a Gene Therapy Trial in Retinitis Pigmentosa" via Labiotech.eu http://bit.ly/HRM11082 horlacher alpirsbach
Horama on Twitter: "Confined yes but still committed ! At Horama ...
WebParis, France – April 20 th, 2024 – Horama, a clinical stage biotechnology company developing life changing gene therapies in rare diseases, announces the appointments … Web10 mrt. 2024 · French biotech Horama has treated the first patients with a gene therapy for retinitis pigmentosa that could prevent the progressive… July 11, 2024 - 3 minutes - By … Web8 nov. 2024 · Horama raises 19 million euros from new investors (Kurma Partners, Fund+, Pontifax and Idinvest) and existing investors (Omnes Capital, GO Capital and Sham … horl7